SYNSIRNA Trademark

Trademark Overview

On Thursday, June 12, 2014, a trademark application was filed for SYNSIRNA with the United States Patent and Trademark Office. The USPTO has given the SYNSIRNA trademark a serial number of 86307986. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 29, 2018. This trademark is owned by Glaxo Group Limited. The SYNSIRNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
synsirna

General Information

Serial Number86307986
Word MarkSYNSIRNA
Filing DateThursday, June 12, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 29, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 23, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, January 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 29, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2017EXTENSION 5 GRANTED
Thursday, June 22, 2017EXTENSION 5 FILED
Tuesday, June 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 22, 2017TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2016EXTENSION 4 GRANTED
Friday, December 16, 2016EXTENSION 4 FILED
Friday, December 16, 2016TEAS EXTENSION RECEIVED
Tuesday, September 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 11, 2016EXTENSION 3 GRANTED
Thursday, June 23, 2016EXTENSION 3 FILED
Thursday, September 1, 2016NOTICE OF REVIVAL - E-MAILED
Thursday, September 1, 2016EXTENSION RECEIVED WITH TEAS PETITION
Thursday, September 1, 2016PETITION TO REVIVE-GRANTED
Thursday, September 1, 2016TEAS PETITION TO REVIVE RECEIVED
Monday, July 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 13, 2016EXTENSION 2 GRANTED
Tuesday, December 22, 2015EXTENSION 2 FILED
Sunday, February 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 22, 2015TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 2, 2015EXTENSION 1 GRANTED
Tuesday, June 2, 2015EXTENSION 1 FILED
Tuesday, June 2, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 18, 2014ASSIGNED TO EXAMINER
Monday, June 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 16, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

synsirna pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological